clinical trial · NCT05170815
Clariance ErYs Registry
Clariance·—·recruiting·n = 760
Spine DegenerationSpine Spondylosis ThoracicSpinal DeformitySpinal TumorSpinal FractureSpine surgery
brief summary
International, prospective, single arm, multicenter and observational Post-Market Clinical Follow-up (PMCF). The overall objective of this study is to collect preoperative, intraoperative and postoperative (at 9 weeks, 6 months, 1 year and 2 years) data on the clinical complications and functional outcomes of the study devices to demonstrate safety and performance in a real-world setting. The primary objective is to demonstrate that the use of the study devices is safe. The secondary objective is to demonstrate that the use of the study devices decreases the pain, and improves the quality of life and the daily activities of the subjects.
started
Jan 17, 2022
primary completion
Dec 1, 2028
completion
Dec 1, 2028
last updated
Mar 17, 2026
official title
Clariance Registry of ERISMA® and Idys® Devices
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol